David Scherr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David Scherr has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Ana Kanazir
Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA
1 shared publicationDavid Nellis
Frederick Manufacturing Center, Manufacturing Sciences and Technology AstraZeneca Frederick Maryland USA
1 shared publicationJan Martinek
Dynamic Omics, Center for Genomic Research, Biopharmaceutical Research and Development AstraZeneca Gaithersburg Maryland USA
1 shared publicationJon Coffman
Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA
1 shared publicationMichael Mollet
Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA
1 shared publicationNikunj Sharda
Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA
1 shared publication
Latest Publications
- Open Access
- 29 October 2026
- Published by Wiley in Biotechnology and Bioengineering
10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy
During bsAb1 purification, precipitate was formed during neutralization of the affinity capture product. This precipitate was removed before loading onto the first polishing column in the Integrated Dynamic Bioprocessing (IDB) platform. The precipitate had a dynamic particle size distribution that caused complex scaling without proper characterization. Herein, the study established a protocol for characterizing downstream precipitate formation and operating a depth filter (Emphaze AEX) like a chromatography column to support continuous purification of bsAb1. The depth filter is “underloaded” with precipitated material, followed by a chase step and the application of sanitization buffers. The sanitization buffers solubilized precipitate bound to the depth filter and controlled bioburden, drastically increasing the filter capacity and helped ensure a closed system. At the bench, the depth filter was cycled 40 times for a total capacity of 10,500 L/m 2 . This capacity is an order of magnitude greater than when the depth filter is loaded to max capacity without any cycling or sanitization. The resulting cycling capacity eases depth filter scale‐up and IDB implementation at the clinical and commercial scale.
- 29 October 2026
- Published by Wiley in Biotechnology and Bioengineering
Open Access10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy
During bsAb1 purification, precipitate was formed during neutralization of the affinity capture product. This precipitate was removed before loading onto the first polishing column in the Integrated Dynamic Bioprocessing (IDB) platform. The precipitate had a dynamic particle size distribution that caused complex scaling without proper characterization. Herein, the study established a protocol for characterizing downstream precipitate formation and operating a depth filter (Emphaze AEX) like a chromatography column to support continuous purification of bsAb1. The depth filter is “underloaded” with precipitated material, followed by a chase step and the application of sanitization buffers. The sanitization buffers solubilized precipitate bound to the depth filter and controlled bioburden, drastically increasing the filter capacity and helped ensure a closed system. At the bench, the depth filter was cycled 40 times for a total capacity of 10,500 L/m 2 . This capacity is an order of magnitude greater than when the depth filter is loaded to max capacity without any cycling or sanitization. The resulting cycling capacity eases depth filter scale‐up and IDB implementation at the clinical and commercial scale.